Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Journal of Cancer (Oxford, England : 1990)|May 30, 2015
Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgeryH Joensuu, J Martin-Broto, T Nishida, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 30, 2016
SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016)A Poveda, V Martinez, C Serrano, et al.
ESMO Open|August 25, 2023
Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategiesJ-Y Blay, M von Mehren, R L Jones, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 2, 2016
SEOM Clinical Guideline of management of soft-tissue sarcoma (2016)A López-Pousa, J Martin Broto, J Martinez Trufero, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 13, 2016
Gastrointestinal stromal tumors (GISTs): SEAP-SEOM consensus on pathologic and molecular diagnosisJ Martin-Broto, V Martinez-Marín, C Serrano, et al.
British Journal of Cancer|August 9, 2017
GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS)J Mora, A Castañeda, S Perez-Jaume, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)<sup>☆</sup>P G Casali, A Le Cesne, A P Velasco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)J Martin-Broto, A Redondo, C Valverde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 2010
Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) StudyJ Martin-Broto, A Gutierrez, X Garcia-Del-Muro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2016
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma GroupA Gronchi, S Stacchiotti, P Verderio, et al.
Pageof 2